Drug
Ixp
Ixp: highest development phase Phase 1, developed by Vertex Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vertex Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| IXP NCT06529796 | Phase 1 | Focal Segmental Glomerulosclerosis (FSGS) |
Latest
No recent events.
Follow Ixp on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.